| Symbol |
Name |
|
AATF
|
apoptosis antagonizing transcription factor
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANP32A
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
AR
|
androgen receptor
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
ARHGAP18
|
Rho GTPase activating protein 18
|
|
ATM
|
ATM serine/threonine kinase
|
|
B4GALNT1
|
beta-1,4-N-acetyl-galactosaminyl transferase 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
CARM1
|
coactivator-associated arginine methyltransferase 1
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASZ1
|
castor zinc finger 1
|
|
CCNA1
|
cyclin A1
|
|
CCNA2
|
cyclin A2
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCNE2
|
cyclin E2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD24
|
CD24 molecule
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRM5
|
cholinergic receptor, muscarinic 5
|
|
CLU
|
clusterin
|
|
CRX
|
cone-rod homeobox
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEGS1
|
delta(4)-desaturase, sphingolipid 1
|
|
DEK
|
DEK proto-oncogene
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FGF7
|
fibroblast growth factor 7
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GPC6
|
glypican 6
|
|
GTF2I
|
general transcription factor IIi
|
|
H2AFX
|
H2A histone family, member X
|
|
HDAC1
|
histone deacetylase 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IL1B
|
interleukin 1, beta
|
|
IL6
|
interleukin 6
|
|
ILK
|
integrin-linked kinase
|
|
IRS1
|
insulin receptor substrate 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KDM4A
|
lysine (K)-specific demethylase 4A
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
KIF14
|
kinesin family member 14
|
|
KRT8
|
keratin 8, type II
|
|
LIMD1
|
LIM domains containing 1
|
|
LMNA
|
lamin A/C
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR101-1
|
microRNA 101-1
|
|
MIR101-2
|
microRNA 101-2
|
|
MIR106A
|
microRNA 106a
|
|
MIR17
|
microRNA 17
|
|
MIR17HG
|
miR-17-92 cluster host gene
|
|
MIR183
|
microRNA 183
|
|
MIR20A
|
microRNA 20a
|
|
MIR21
|
microRNA 21
|
|
MIR215
|
microRNA 215
|
|
MIR376A1
|
microRNA 376a-1
|
|
MIR449A
|
microRNA 449a
|
|
MIR449B
|
microRNA 449b
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MKL2
|
MKL/myocardin-like 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
NANOS1
|
nanos homolog 1 (Drosophila)
|
|
NBN
|
nibrin
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NDP
|
Norrie disease (pseudoglioma)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGFR
|
nerve growth factor receptor
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
|
PAX6
|
paired box 6
|
|
PCAT4
|
prostate cancer associated transcript 4 (non-protein coding)
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PLK1
|
polo-like kinase 1
|
|
POLA1
|
polymerase (DNA directed), alpha 1, catalytic subunit
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU3F2
|
POU class 3 homeobox 2
|
|
PPP1R10
|
protein phosphatase 1, regulatory subunit 10
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBBP4
|
retinoblastoma binding protein 4
|
|
RBL1
|
retinoblastoma-like 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SRGAP2
|
SLIT-ROBO Rho GTPase activating protein 2
|
|
TACR1
|
tachykinin receptor 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
|
|
TFF1
|
trefoil factor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TMPO
|
thymopoietin
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TYMS
|
thymidylate synthetase
|
|
UBR4
|
ubiquitin protein ligase E3 component n-recognin 4
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
XRCC6P3
|
X-ray repair complementing defective repair in Chinese hamster cells 6 pseudogene 3
|
|
YY1
|
YY1 transcription factor
|
